HIKAL
Quarterly Results Analysis [Mar2025]
HIKAL Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹552 Cr | ₹448 Cr | ₹453 Cr | ₹407 Cr | ₹514 Cr | ₹448 Cr | ₹435 Cr | ₹388 Cr |
Expenses | ₹429 Cr | ₹376 Cr | ₹378 Cr | ₹349 Cr | ₹420 Cr | ₹383 Cr | ₹377 Cr | ₹338 Cr |
Operating Income | ₹123 Cr | ₹72 Cr | ₹75 Cr | ₹58 Cr | ₹94 Cr | ₹65 Cr | ₹58 Cr | ₹50 Cr |
Other Income | ₹1 Cr | ₹4 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹20 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr |
Depreciation | ₹38 Cr | ₹33 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹29 Cr | ₹29 Cr | ₹28 Cr |
Profit Before Tax | ₹68 Cr | ₹24 Cr | ₹25 Cr | ₹7 Cr | ₹47 Cr | ₹22 Cr | ₹17 Cr | ₹10 Cr |
Profit After Tax | ₹50 Cr | ₹17 Cr | ₹18 Cr | ₹5 Cr | ₹34 Cr | ₹16 Cr | ₹13 Cr | ₹7 Cr |
EPS | ₹4.06 | ₹1.39 | ₹1.48 | ₹0.41 | ₹2.74 | ₹1.30 | ₹1.02 | ₹0.56 |
Industry Peers & Returns | 1W | 1M | 1Y |
HIKAL | -0.3% | -10.1% | -4.7% |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
CIPLA | -1.7% | -1.1% | -2.3% |
TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
MANKIND PHARMA | 6.8% | 8% | 20.9% |
ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
LUPIN | -4.3% | -6.4% | 4.6% |
HIKAL Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 23.39 % |
Y-o-Y | 7.45 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹552 Cr | 23.39 | |
Dec2024 | ₹448 Cr | -1.15 | |
Sep2024 | ₹453 Cr | 11.33 | |
Jun2024 | ₹407 Cr | -20.87 | |
Mar2024 | ₹514 Cr | 14.88 | |
Dec2023 | ₹448 Cr | 2.90 | |
Sep2023 | ₹435 Cr | 12.09 | |
Jun2023 | ₹388 Cr | - |
HIKAL Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 71.15 % |
Y-o-Y | 30.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹123 Cr | 71.15 | |
Dec2024 | ₹72 Cr | -3.74 | |
Sep2024 | ₹75 Cr | 29.14 | |
Jun2024 | ₹58 Cr | -38.56 | |
Mar2024 | ₹94 Cr | 45.90 | |
Dec2023 | ₹65 Cr | 12.33 | |
Sep2023 | ₹58 Cr | 14.51 | |
Jun2023 | ₹50 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 38.76 % |
Y-o-Y | 21.68 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 22.34% | 38.76 | |
Dec2024 | 16.1% | -2.66 | |
Sep2024 | 16.54% | 15.99 | |
Jun2024 | 14.26% | -22.33 | |
Mar2024 | 18.36% | 26.97 | |
Dec2023 | 14.46% | 9.21 | |
Sep2023 | 13.24% | 2.16 | |
Jun2023 | 12.96% | - |
HIKAL Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 191.86 % |
Y-o-Y | 48.08 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹50 Cr | 191.86 | |
Dec2024 | ₹17 Cr | -6.01 | |
Sep2024 | ₹18 Cr | 258.82 | |
Jun2024 | ₹5 Cr | -84.96 | |
Mar2024 | ₹34 Cr | 110.56 | |
Dec2023 | ₹16 Cr | 27.78 | |
Sep2023 | ₹13 Cr | 82.61 | |
Jun2023 | ₹7 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 136.72 % |
Y-o-Y | 37.94 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 9.09 % | 136.72 | |
Dec2024 | 3.84 % | -4.95 | |
Sep2024 | 4.04 % | 223.20 | |
Jun2024 | 1.25 % | -81.03 | |
Mar2024 | 6.59 % | 83.06 | |
Dec2023 | 3.6 % | 24.14 | |
Sep2023 | 2.9 % | 62.92 | |
Jun2023 | 1.78 % | - |
HIKAL Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 192.09 % |
Y-o-Y | 48.18 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹4.06 | 192.09 | |
Dec2024 | ₹1.39 | -6.08 | |
Sep2024 | ₹1.48 | 260.98 | |
Jun2024 | ₹0.41 | -85.04 | |
Mar2024 | ₹2.74 | 110.77 | |
Dec2023 | ₹1.3 | 27.45 | |
Sep2023 | ₹1.02 | 82.14 | |
Jun2023 | ₹0.56 | - |
You may also like the below Video Courses